Abstract
Evidence of androgenetic alopecia, or male pattern baldness, can be distressing for transgender women. Here we present the case of a transgender woman with scalp hair regrowth after ∼6 months on oral estradiol and spironolactone therapy achieving testosterone levels within normal female range.
Highlights
Androgenetic alopecia, known as male pattern baldness, is a process by which hair loss from the scalp occurs in a progressive, predictable pattern
There are currently only two FDA-approved treatments for androgenetic alopecia and both are more effective in arresting hair loss than in reversing it.[1]
We present the case of a transgender woman with scalp hair regrowth while on hormone therapy with oral estradiol and spironolactone
Summary
Androgenetic alopecia, known as male pattern baldness, is a process by which hair loss from the scalp occurs in a progressive, predictable pattern.Recent research has proposed that it is a result of the presence of sufficient androgen, dihydrotestosterone (DHT), in a person with genetic predisposition.[1]. Androgenetic alopecia, known as male pattern baldness, is a process by which hair loss from the scalp occurs in a progressive, predictable pattern.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have